article thumbnail

MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF

Cannabis Law Report

(TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. These projects will all require pharmaceutical approved API if commercialized. Management Commentary.

article thumbnail

Expert Gives Delta-8 THC Thumbs Down

Project CBD

Project CBD: Your presentation with Allyn Howlett at the International Cannabinoid Research Society conference in Toronto (June 2023) discussed the chemical conversion of CBD into Δ8-THC (delta-8 THC) and “numerous additional THC isomers. At issue are potent, intoxicating cannabinoids other than cannabis-derived Δ9-THC.

THC 212
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Our lead product, ANEB-001, has the potential to rapidly reverse the effects of acute cannabinoid intoxication, a relatively unknown yet serious affliction that sends more than 5,000 Americans to the hospital emergency department every day.

article thumbnail

CBD, THC & CBG for Skin Conditions

Project CBD

Anyone who has paid any attention to the cannabis “wellness” industry in recent years — whether through state medical and recreational programs or the free-for-all national CBD market — will be familiar with cannabinoid-infused topicals marketed to treat minor aches and pains.

article thumbnail

An Introduction to the CBN Cannabinoid

Kind Meds (Cannabis Education Blog)

Lately, the cannabinoid CBN (or cannabinol) has been rising in popularity. CBN is a cannabinoid that can be synthesized out of THC. Cannabinol – more commonly known as CBN – is one of over one hundred cannabinoids found in the cannabis plant. The CBN cannabinoid begins to form when THC is oxidized. What Is CBN?

article thumbnail

Nextleaf Focused on Owning The Largest Patent Portfolio for the Extraction, Distillation, and Delivery of Cannabinoids

Cannabis Law Report

Nextleaf Solutions’s technologies are focused on transforming cannabis or hemp biomass to a standardized cannabinoid oil as efficiently as possible. Ultrasonic extraction has been noted as an effective and rapid technique for extracting cannabis concentrate, and now Nextleaf has taken this technology to the next level. While the U.S.

article thumbnail

Protonify launches global cannabis research partnership campaign

Cannabis Law Report

Under this new program, Protonify will provide cannabis researchers with complimentary access to its high-purity, pharmaceutical-grade cannabinoid ingredients including THC concentrate and THCA isolate.